Hypofractionated Stereotactic Radiation Therapy of Brain Metastases:

See also
Status	Clinical Trial	Phase
Withdrawn	`NCT01913067` - Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC	Phase 2
Completed	`NCT02662725` - Ipilimumab Combined With a Stereotactic Radiosurgery in Melanoma Patients With Brain Metastases	Phase 2
Completed	`NCT00406835` - Prospective Randomized Trial Between WBRT Plus SRS Versus SRS Alone for 1-4 Brain Metastases	Phase 3
Completed	`NCT01724801` - Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer	Phase 3
Completed	`NCT00219297` - Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer	Phase 2
Withdrawn	`NCT02328300` - FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions
Terminated	`NCT01324635` - Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors	Phase 1
Terminated	`NCT01894633` - Study of Whole-brain Irradiation With Chloroquine for Brain Metastases	Phase 2
Recruiting	`NCT02681549` - Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer	Phase 2
Terminated	`NCT02279992` - Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases	Early Phase 1
Completed	`NCT01942980` - Evaluation of the Efficacy of Hippocampal Avoidance on the Cognitive Toxicity of Whole-Brain Radiation Therapy After Surgical Resection of Single Brain Metastasis of Breast Cancer	Phase 3
Terminated	`NCT01363557` - Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain Metastasis	N/A
Active, not recruiting	`NCT05102747` - Stereotactic Radiotherapy in Oligometastatic Brain Disease: a Randomised Phase III Study Comparing Hypofractionated Stereotactic Radiation Therapy (310 Gy) to the Historical Single-dose Radiosurgery (120 to 25 Gy) With Medico-economic Evaluation.	N/A
Recruiting	`NCT01891708` - VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer	N/A
Completed	`NCT01508221` - Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis	Phase 2
Completed	`NCT00587964` - Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases	Phase 2
Not yet recruiting	`NCT02832635` - A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases	Phase 2
Completed	`NCT01395407` - Phase I Trial of Stereotactic Radiosurgery Following Surgical Resection of Brain Metastases	Phase 1
Terminated	`NCT02433171` - Methionine and PBR28-PET (Peripheral Benzodiazepine Receptors) in Brain Metastases Following Radiosurgery
Recruiting	`NCT02504788` - A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline	N/A

NCT number	NCT02913534
Study type	Observational
Source	Institut de Cancérologie de Lorraine
Contact
Status	Completed
Phase	N/A
Start date	March 2014
Completion date	June 2014

Hypofractionated Stereotactic Radiation Therapy of Brain Metastases: Evaluation of Whole-brain Radiotherapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms